Summary
BlackRock Health Sciences Opportunities Portfolio is a mutual fund run by BlackRock. It does not trade on an exchange: you buy it from the fund company at a price set once a day. Positions inside: 139. The ten largest make up 53% of the fund.
- Yearly costs
- 1.90%
- Fund size
- $6.33B
- Positions
- 139
- Dividend yield
- 19.17%
- Running since
- 2000
What speaks for it
- A large fund with $6.33B under management.
- It has been running since 2000.
What to watch
- The ten largest positions make up 53% of the fund, so its result rests on a few names.
- Costs of 1.90% a year are above the middle of comparable funds (0.40%).
- In the last five years its price once dropped by 36% from its high.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +1.6%
- 3 months
- -5.6%
- This year
- -3.2%
- 1 year
- -2.4%
- 3 years
- -5.8%
- 5 years
- -26%
- 10 years
- +16%
- Avg. market cap
- $190.9B
- P/E
- 37.3x
- Forward P/E
- 24.5x
- P/S
- 2.5x
- P/B
- 5.9x
- P/FCF
- 23.3x
- EV/EBITDA
- 21.9x
- Dividend yield
- 0.94%
- ROIC
- 5.0%
- ROE
- 13.3%
- Gross margin
- 66.0%
- Operating margin
- -74.8%
- Net margin
- -24.8%
- Payout ratio
- 35.0%
- Net debt/EBITDA
- 2.0x
- Beta
- 0.50
Weighted average of the 50 largest companies, which make up 62% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 ELI LILLY 12%
- 2 JNJOHNSON & JOHNSON JNJ.TO 8.0%
- 3 MRMerck & Co. MRK 5.6%
- 4 ABAbbVie Inc. ABBV.BA 5.1%
- 5 TMThermo Fisher Scientific Inc. TMO.TO 4.4%
- 6 UNUnitedHealth Group Incorporated UNH.BA 4.3%
- 7 GIGilead Sciences, Inc. GILD.TO 4.1%
- 8 AMAmgen AMGN 4.0%
- 9 VRVertex Pharmaceuticals VRTX 3.3%
- 10 ABAbbott Laboratories ABT 2.6%
Positions in the fund: 139. The ten largest make up 53% of it.
Composition as of Oct 18, 2026.
Where is it spread?
Spread outBy country
- United States 73%
- Netherlands 1.5%
- Switzerland 1.3%
- Israel 1.2%
- Other countries 23%
By company size
- Mega cap 36%
- Large cap 50%
- Mid cap 8.5%
- Small cap 4.5%
- Micro cap 0.3%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 66% of the fund.
Largest country: United States (73%). Largest size group: Large cap (50%).
What does it cost me?
Expensive- A year from $10,000
- $190
- Over 20 years
- $8,118
From every $10,000 invested the fund takes $190 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $8,118.
How has it done?
Growing slowly- A year on average, 10 years
- +1.5%
- Deepest drop
- -36%
- Yearly volatility
- 22%
Average yearly growth over the last ten years: 1.5%. Deepest drop in these years: 36% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 19.17%
- Payments a year
- 1
- Last payment
- $6.46
Over the last 12 months it paid $9.32 per share, which is 19.17% of today's price. The last payment was $6.46 on Jul 22, 2026.
How expensive are the companies inside?
Rather expensive- P/E of the companies inside
- 37.3
- Average Bulios Score
- 53 out of 100
Weight by Bulios Fair Price
- Undervalued 7.3%
- Fairly valued 36%
- Overvalued 57%
On average the companies inside trade for 37.3 times their yearly profit. By Fair Price, 57% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 62% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Can I buy it as an ETF?
A mutual fund is bought from the fund company. These ETFs hold much of the same and trade on an exchange, so an ordinary broker carries them.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
PB PBPH Portfolio Building Block World Pharma and Biotech Index ETF | United States | 0.13% | $12.8M | - | - | 34% |
BM BMED iShares Health Innovation Active ETF | United States | 0.77% | $13.8M | +22% | Pays out | 27% |
VH VHT Vanguard Health Care ETF | United States | 0.09% | $21.7B | +20% | Pays out | 25% |
FH FHLC Fidelity MSCI Health Care Index ETF | United States | 0.08% | $3.54B | +21% | Pays out | 24% |
IY IYH iShares U.S. Healthcare ETF | United States | 0.37% | $4.33B | +21% | Pays out | 24% |
ZP ZPDH.DE State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) | Ireland | 0.15% | $619.4M | +28% | Reinvests | 23% |